Round and Round Spins the Revolving Door, Unimpeded by "Obamacare," Nor By Those Protesting "Obamacare"
On this day of government dysfunction in the US, it is time for our latest installment on the "revolving door," the interchange of insiders among government legislative offices that affect health policy and agencies that implement it, and large health care corporations and the lobbyists and attorneys who represent them. While we have been discussing this issue since March, 2011 (look here), it got major media attention in the form of a New York Times article two weeks ago.
We have accumulated several other relevant stories since late August, 2013, which we will group by the type of government offices and agencies affected, and within them, by the date the story first came out..
Regulatory and Law Enforcement Agencies
Health Care Antitrust Leader at the Federal Trade Commission to Arnold & Porter
From the MainJustice.com site,
So,
Leader of Health Care Fraud Enforcement for US Attorney New Jersey Office to Lowenstein Sandler
From the ComplianceWeek.com site,
Health Policy Implementation
Counsel for Department of Health and Human Services to Sidley Austin
Per the NY Times,
Previously,
Deputy Assistant Secretary of Department of Health and Human Services to Glover Park Group
Also from the NY Times,
White House to Avenue Solutions
From the NY Times,
White House "Health Czar" and Deputy Chief of Staff to Consonance Capital, and CVS
While we noted this in August, 2013, the NY Times reported in September as part of its larger article,
Actually, as we discussed in 2009, Ms DeParle has been oscillating back and forth through the revolving door for a while. She was the administrator of the Health Care Financing Administration in the Department of Health and Human Services under President Clinton from 1997-2000. She left to become managing director of a private equity firm, CCMP Capital. She also served on the boards of directors of Boston Scientific, Cerner, and Medco. Then she went back to the executive branch as noted by the the Times above.
Furthermore, as reported by AP, via the Providence Journal,
White House to health care venture capital
Also from the NY Times story,
Legislative Offices
Senate Finance Committee Staff, then Department of Health and Human Services Staff to Avenue Solutions
As reported by The Hill bog,
Congress to Alston & Bird
In the same report,
Health Counsel for Senate Finance Committee from WellPoint, Now to Johnson & Johnson
Note that we touched on part of this story back in 2010 here. Now from the New York Times,
We have accumulated several other relevant stories since late August, 2013, which we will group by the type of government offices and agencies affected, and within them, by the date the story first came out..
Regulatory and Law Enforcement Agencies
Health Care Antitrust Leader at the Federal Trade Commission to Arnold & Porter
From the MainJustice.com site,
Peter J Levitas, a former senior antiturst attorney at the Federal Trade Commission, is joining Arnold & Porter LLP in Washington, D.C....
Levitas has spent the past four years as deputy director of the FTC's Bureau of Competition and oversaw investigations and litigation for mergers and conduct cases in numerous industries.
So,
Levitas joins the firm's antitrust practice with experience3 addressing complex merger and conduct investigations, particularly in the healthcare, pharmaceutical and technology industries.
Leader of Health Care Fraud Enforcement for US Attorney New Jersey Office to Lowenstein Sandler
From the ComplianceWeek.com site,
Maureen Ruane, a former health care fraud chief at the U.S. Attorney's Office for the District of New Jersey, has rejoined the law firm Lowenstein Sandler to lead its new health care litigation, investigations and compliance practice.
The new practice will help the firm's healthcare and life science clients strengthen their regulatory and compliance programs, as well as defend corporate and individual clients who become the subjects or targets of government investigations or enforcement actions.
Prior to rejoining Lowenstein Sandler, Ruane most recently served for more than three years as the Chief of the Health Care & Government Fraud Unit at the U.S. Attorney's Office for the District of New Jersey.
Health Policy Implementation
Counsel for Department of Health and Human Services to Sidley Austin
Per the NY Times,
Dr. [Dora] Hughes, a former Obama administration official, has something Washington lawyers and lobbying shops covet: an insider’s understanding of the new health care law. After nearly four years as counselor to Health and Human Services Secretary Kathleen Sebelius, she left government last year to work for Sidley Austin, which represents insurers, pharmaceutical companies, device makers and others affected by the law.
Previously,
she began a decade ago, first as a health policy adviser to Senator Edward M. Kennedy, and later to Mr. Obama, then a senator.
Deputy Assistant Secretary of Department of Health and Human Services to Glover Park Group
Also from the NY Times,
Elizabeth Engel, who oversaw health legislation and served as a liaison to Congress when she was a deputy assistant health secretary under Ms. Sebelius, is now advising health care clients for the Glover Park Group.
White House to Avenue Solutions
From the NY Times,
Yvette Fontenot, a mother of three who began her Washington career in 1997, analyzing Medicare for the Office of Management and Budget. Ms. Fontenot worked on the health bill as a Finance Committee aide and later moved to the White House. Four months ago she joined Avenue Solutions, a boutique lobbying shop.
White House "Health Czar" and Deputy Chief of Staff to Consonance Capital, and CVS
While we noted this in August, 2013, the NY Times reported in September as part of its larger article,
Nancy-Ann DeParle, Mr. Obama’s former 'health czar' and later his deputy chief of staff, now guides health care investments as a partner in a new private equity firm, Consonance Capital, with colleagues from her pre-White House days.
Actually, as we discussed in 2009, Ms DeParle has been oscillating back and forth through the revolving door for a while. She was the administrator of the Health Care Financing Administration in the Department of Health and Human Services under President Clinton from 1997-2000. She left to become managing director of a private equity firm, CCMP Capital. She also served on the boards of directors of Boston Scientific, Cerner, and Medco. Then she went back to the executive branch as noted by the the Times above.
Furthermore, as reported by AP, via the Providence Journal,
Drugstore chain CVS Caremark has added to its board of directors a former top adviser to President Barack Obama on the health care overhaul.
The Woonsocket, R.I., company said Wednesday after markets closed that Nancy-Ann M. DeParle, 56, will be an independent director who serves on the board's audit committee.
White House to health care venture capital
Also from the NY Times story,
Bob Kocher, a doctor, management consultant and former member of Mr. Obama’s economics team, is a California venture capitalist, helping finance health start-ups.
Legislative Offices
Senate Finance Committee Staff, then Department of Health and Human Services Staff to Avenue Solutions
As reported by The Hill bog,
The firm Avenue Solutions, for instance, recently hired Yvette Fontenot, a former staffer for both the Senate Finance Committee, which wrote ObamaCare’s tax-related provisions, and HHS's Office of Health Reform, which is assisting the implementation.
Since her hire in April, the four-woman firm has picked up Health Care Service Corp. as a client, and Fontenot is now lobbying for the Blue Cross Blue Shield Association
Congress to Alston & Bird
In the same report,
Former Rep. Earl Pomeroy (D-N.D.) joined Alston & Bird in 2011 after dealing with healthcare and tax issues as a member of the House Ways and Means Committee.
Now Pomeroy and his one-time chief of staff, Bob Siggins, are lobbying on ObamaCare for clients such as clients such as Vision Service Plan, the National Coordinating Committee for Multiemployer Plans and Medicare — a health insurance provider.
Health Counsel for Senate Finance Committee from WellPoint, Now to Johnson & Johnson
Note that we touched on part of this story back in 2010 here. Now from the New York Times,
Liz Fowler, a onetime executive with WellPoint, the insurer, helped draft the legislation as the chief health counsel for the Senate Finance Committee and later joined the administration. Now she runs global health policy for Johnson & Johnson, the medical equipment and pharmaceutical giant, which strongly backed the health bill and stands to benefit from it.Ms. Fowler is not a registered lobbyist, but she does provide in-house advice on the bill — work that has drawn criticism from publications like the British newspaper The Guardian and the Web sites Salon and The Huffington Post, where the journalist Bill Moyers singled out Ms. Fowler, asserting that 'when push comes to shove, corporate interests will have the upper hand.'
Summary
It's enough to make one's head spin: all that traffic through the revolving door reported just in the last five weeks.
As we have said many times before, the constant interchange of health care insiders among government offices, lobbying and legal firms, and large health care corporations certainly suggests that health care, like many other sectors, seems to be run by an amorphous group of insiders who owe allegiance neither to government nor industry. The NY Times tried to explain this in a benign way,
Yet the progression from government to the private sector is also predictable, a window into the peculiar rhythms of life in the capital. Young aides, often fresh out of college or graduate school, acquire highly specialized knowledge but eventually settle down, build lives and long for jobs that pay more and let them see their children at night.
While the private sector may offer good pay, is it just for these poeples' skills and expertise? Or are these offers only for those who while in government service evinced friendship to private vested interests? Do government workers who think longingly of higher pay and shorter hours wonder what it would take to please those that might offer such opportunities?
Yet those who work in government are supposed to be working for the people, and those who work on health care within government are supposed to be working for patients' and the public health. If they are constantly looking over their shoulders at potential private employers who might offer big checks, who indeed are they working for?
Attempts to turn government toward private gain and away from being of the people, by the people, and for the people have no doubt been going on since the beginning of government (and since the Constitution was signed, in the case of the US). However, true health care reform would require curtailing the severe sorts of conflicts of interest created by the revolving door. This might require both improving pay and working conditions for government regulators, law enforcers, and legislative staffers; and specific laws to prevent immediate transitions from being a regulator, law enforcer, or legislator to handling corporate responses to or defenses against such regulation and enforcement.
That bit does not seem to be part of the current Affordable Care Act, yet it was hardly to enact such restrictions on conflict of interest that certain members of Congress have shut down the government.
Round and Round Spins the Revolving Door, Unimpeded by "Obamacare," Nor By Those Protesting "Obamacare"
Reviewed by MCH
on
October 02, 2013
Rating:
No comments: